Buchumschlag

Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer

TRAIL selectively kills cancer cells while bispecific antibody EpCAMxCD3 guides effector lymphocytes to cancer cells. Arming of ex vivo constructed TRAIL-lymphocytes with EpCAMxCD3 enhances contact time and affinity between lymphocytes and tumor cells and enforces tumor elimination. This boosts endo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Herr, Ingrid (VerfasserIn) , Salnikov, Alexey V. (VerfasserIn) , Büchler, Markus W. (VerfasserIn) , Moldenhauer, Gerhard (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 24 Aug 2012
In: OncoImmunology
Year: 2012, Jahrgang: 1, Heft: 5, Pages: 741-743
ISSN:2162-402X
DOI:10.4161/onci.19532
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.4161/onci.19532
Verlag, kostenfrei, Volltext: https://doi.org/10.4161/onci.19532
Volltext
Verfasserangaben:Ingrid Herr, Ariane Groth, Alexei V. Salnikov, Markus W. Büchler and Gerhard Moldenhauer

MARC

LEADER 00000caa a2200000 c 4500
001 1576189007
003 DE-627
005 20220814155849.0
007 cr uuu---uuuuu
008 180608s2012 xx |||||o 00| ||eng c
024 7 |a 10.4161/onci.19532  |2 doi 
035 |a (DE-627)1576189007 
035 |a (DE-576)506189007 
035 |a (DE-599)BSZ506189007 
035 |a (OCoLC)1341011182 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Herr, Ingrid  |e VerfasserIn  |0 (DE-588)114884242  |0 (DE-627)691233276  |0 (DE-576)168702436  |4 aut 
245 1 0 |a Combining forces to hit cancer stem cells  |b TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer  |c Ingrid Herr, Ariane Groth, Alexei V. Salnikov, Markus W. Büchler and Gerhard Moldenhauer 
264 1 |c 24 Aug 2012 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.06.2018 
520 |a TRAIL selectively kills cancer cells while bispecific antibody EpCAMxCD3 guides effector lymphocytes to cancer cells. Arming of ex vivo constructed TRAIL-lymphocytes with EpCAMxCD3 enhances contact time and affinity between lymphocytes and tumor cells and enforces tumor elimination. This boosts endogenous immune responses and augments the effect of cytotoxic tumor therapy. 
700 1 |a Salnikov, Alexey V.  |e VerfasserIn  |0 (DE-588)1156427118  |0 (DE-627)1019253800  |0 (DE-576)502180390  |4 aut 
700 1 |a Büchler, Markus W.  |d 1955-  |e VerfasserIn  |0 (DE-588)120893339  |0 (DE-627)080952526  |0 (DE-576)292434146  |4 aut 
700 1 |a Moldenhauer, Gerhard  |e VerfasserIn  |0 (DE-588)1054128634  |0 (DE-627)791055701  |0 (DE-576)410008443  |4 aut 
773 0 8 |i Enthalten in  |t OncoImmunology  |d Abingdon : Taylor & Franics, 2012  |g 1(2012), 5, Seite 741-743  |h Online-Ressource  |w (DE-627)683365428  |w (DE-600)2645309-5  |w (DE-576)356728366  |x 2162-402X  |7 nnas  |a Combining forces to hit cancer stem cells TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer 
773 1 8 |g volume:1  |g year:2012  |g number:5  |g pages:741-743  |g extent:3  |a Combining forces to hit cancer stem cells TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer 
856 4 0 |u http://dx.doi.org/10.4161/onci.19532  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://doi.org/10.4161/onci.19532  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180608 
993 |a Article 
994 |a 2012 
998 |g 1054128634  |a Moldenhauer, Gerhard  |m 1054128634:Moldenhauer, Gerhard  |d 910000  |e 910000PM1054128634  |k 0/910000/  |p 5  |y j 
998 |g 120893339  |a Büchler, Markus W.  |m 120893339:Büchler, Markus W.  |d 910000  |d 910200  |e 910000PB120893339  |e 910200PB120893339  |k 0/910000/  |k 1/910000/910200/  |p 4 
998 |g 1156427118  |a Salnikov, Alexey V.  |m 1156427118:Salnikov, Alexey V.  |d 910000  |e 910000PS1156427118  |k 0/910000/  |p 3 
998 |g 114884242  |a Herr, Ingrid  |m 114884242:Herr, Ingrid  |d 910000  |e 910000PH114884242  |k 0/910000/  |p 1  |x j 
999 |a KXP-PPN1576189007  |e 3012233709 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Ingrid Herr, Ariane Groth, Alexei V. Salnikov, Markus W. Büchler and Gerhard Moldenhauer"]},"recId":"1576189007","id":{"doi":["10.4161/onci.19532"],"eki":["1576189007"]},"origin":[{"dateIssuedDisp":"24 Aug 2012","dateIssuedKey":"2012"}],"language":["eng"],"physDesc":[{"extent":"3 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"display":"Herr, Ingrid","role":"aut","given":"Ingrid","family":"Herr"},{"display":"Salnikov, Alexey V.","role":"aut","given":"Alexey V.","family":"Salnikov"},{"family":"Büchler","role":"aut","given":"Markus W.","display":"Büchler, Markus W."},{"family":"Moldenhauer","role":"aut","given":"Gerhard","display":"Moldenhauer, Gerhard"}],"title":[{"title_sort":"Combining forces to hit cancer stem cells","title":"Combining forces to hit cancer stem cells","subtitle":"TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer"}],"relHost":[{"note":["Gesehen am 13.12.2022"],"titleAlt":[{"title":"Onco Immunology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2012 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"OncoImmunology","title_sort":"OncoImmunology"}],"recId":"683365428","disp":"Combining forces to hit cancer stem cells TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancerOncoImmunology","origin":[{"publisherPlace":"Abingdon ; Austin, Tex.","dateIssuedDisp":"2012-","dateIssuedKey":"2012","publisher":"Taylor & Franics ; Landes Bioscience"}],"id":{"zdb":["2645309-5"],"issn":["2162-402X"],"eki":["683365428"]},"part":{"year":"2012","issue":"5","extent":"3","text":"1(2012), 5, Seite 741-743","pages":"741-743","volume":"1"}}],"note":["Gesehen am 08.06.2018"]} 
SRT |a HERRINGRIDCOMBININGF2420 

Ähnliche Einträge